Gilead Sciences
GILD
1,100 hedge funds and large institutions have $124B invested in Gilead Sciences in 2013 Q4 according to their latest regulatory filings, with 173 funds opening new positions, 396 increasing their positions, 427 reducing their positions, and 47 closing their positions.
268% more first-time investments, than exits
New positions opened: 173 | Existing positions closed: 47
32% more funds holding in top 10
Funds holding in top 10: 114 → 151 (+37)
27% more capital invested
Capital invested by funds: $97.4B → $124B (+$26.1B)
12% more funds holding
Funds holding: 982 → 1,100 (+118)
7% less repeat investments, than reductions
Existing positions increased: 396 | Existing positions reduced: 427
64% less call options, than puts
Call options by funds: $1.03B | Put options by funds: $2.87B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$434M |
| 2 |
Temasek Holdings
Singapore
|
+$393M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$241M |
| 4 |
MC
Montag & Caldwell
Atlanta,
Georgia
|
+$212M |
| 5 |
Goldman Sachs
New York
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.63B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.23B |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$909M |
| 4 |
Jennison Associates
New York
|
-$556M |
| 5 |
O
OppenheimerFunds
New York
|
-$498M |
GILD Hedge Fund Activity: Q4 2013 in Review
1,100 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2013, worth a combined $124B — up 27% from $97.4B a quarter earlier.
Buyers outnumbered sellers: 173 funds opened new GILD positions and 47 closed out — a net gain of 126 holders — while 396 added to existing stakes and 427 trimmed.
The largest buyer was Brown Advisory, adding an estimated $434M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $1.63B.
- 1,100 institutional investors held Gilead Sciences (GILD) as of Q4 2013, up from 982 in Q3 2013.
- Funds reported $124B of Gilead Sciences stock for Q4 2013, up 27% quarter-over-quarter.
- 173 funds opened new Gilead Sciences positions in Q4 2013 and 47 closed out, a net change of +126 holders.
- The largest Gilead Sciences buyer in Q4 2013 was Brown Advisory, an estimated $434M added.
- The largest Gilead Sciences seller in Q4 2013 was BNP Paribas Financial Markets, an estimated $1.63B sold.
Based on aggregated 13F filings for Q4 2013.